Commonwealth Equity Services
PBYI icon

Commonwealth Equity Services’s Puma Biotechnology PBYI Stock Holding History

Commonwealth Equity Services’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,790
Closed -$28K – 4184
2024
Q3 		$28K Hold
10,790
– – ﹤0.01% 3982
2024
Q2 		$35K Hold
10,790
– – ﹤0.01% 3925
2024
Q1 		$57K Buy
10,790
+41
+0.4% +$221 ﹤0.01% 3877
2023
Q4 		$47K Hold
10,749
– – ﹤0.01% 3762
2023
Q3 		$28K Hold
10,749
– – ﹤0.01% 3710
2023
Q2 		$38K Hold
10,749
– – ﹤0.01% 3694
2023
Q1 		$33K Sell
10,749
-110
-1% -$415 ﹤0.01% 3622
2022
Q4 		$45K Buy
+10,859
New +$37.5K ﹤0.01% 3527

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Commonwealth Equity Services's PBYI Position: Q4 2024 in Review

Commonwealth Equity Services sold out of Puma Biotechnology (PBYI) in Q4 2024, closing a stake of 10,790 shares — an estimated $28K sold.

Commonwealth Equity Services first reported a position in PBYI in Q4 2022 and held it in 8 quarters. The position peaked at $57K in Q1 2024. 112 funds tracked by Wall St. Rank hold PBYI as of Q4 2024.

  • Commonwealth Equity Services reported no remaining Puma Biotechnology position as of Q4 2024 after selling out during the quarter.
  • Commonwealth Equity Services sold 10,790 Puma Biotechnology shares in Q4 2024, an estimated $28K.
  • Commonwealth Equity Services first reported a position in Puma Biotechnology in Q4 2022 and held it in 8 quarters.
  • Commonwealth Equity Services's Puma Biotechnology position peaked at $57K in Q1 2024.
  • 112 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2024.

Based on Commonwealth Equity Services's 13F filing for Q4 2024, filed 10 Feb 2025.